Search research articles
Contact Us
Filters
Showing results (661-670 of 676) with videos related to
Page
of 68
Sort By:
Frontiers in Immunology
|
September 12, 2022
Serum cytokine levels are associated with tumor progression during FOLFIRINOX chemotherapy and overall survival in pancreatic cancer patients
Fleur van der Sijde, Willem A Dik, Dana A M Mustafa, et al.
Journal for Immunotherapy of Cancer
|
July 22, 2020
Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model
Sai Ping Lau, Nadine van Montfoort, Priscilla Kinderman, et al.
Scientific Reports
|
November 29, 2025
Treatment outcomes of sunitinib and/or pazopanib in advanced alveolar soft part sarcoma: A Turkish Oncology Group (TOG) study
Zehra Sucuoğlu İşleyen, Seval Ay, Ertuğrul Bayram, et al.
Kidney International
|
December 21, 2023
Multiomic profiling of transplant glomerulopathy reveals a novel T-cell dominant subclass
Iacopo Cristoferi, Hilal Varol, Myrthe van Baardwijk, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 1, 2022
Autologous dendritic cells pulsed with allogeneic tumour cell lysate induce tumour-reactive T-cell responses in patients with pancreatic cancer: A phase I study
S P Lau, L Klaase, M Vink, et al.
Therapeutic Advances in Medical Oncology
|
August 23, 2021
Circulating <i>TP53</i> mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX
Fleur van der Sijde, Zakia Azmani, Marc G Besselink, et al.
Techniques in Coloproctology
|
April 15, 2024
Comparative study of laparoscopic ventral mesh rectopexy versus perineal stapler resection for external full-thickness rectal prolapse in elderly patients: enhanced outcomes and reduced recurrence rates-a retrospective cohort study
T A A M Habeeb, M Podda, M Chiaretti, et al.
International Journal of Molecular Sciences
|
October 23, 2021
Serum miR-373-3p and miR-194-5p Are Associated with Early Tumor Progression during FOLFIRINOX Treatment in Pancreatic Cancer Patients: A Prospective Multicenter Study
Fleur van der Sijde, Marjolein Y V Homs, Marlies L van Bekkum, et al.
World Journal of Gastrointestinal Surgery
|
March 10, 2023
Hepatobiliary manifestations following two-stages elective laparoscopic restorative proctocolectomy for patients with ulcerative colitis: A prospective observational study
Tamer A A M Habeeb, Abdulzahra Hussain, Mauro Podda, et al.
BMC Cancer
|
February 14, 2026
Evaluation of the efficacy and tolerability of bevacizumab-based treatments in recurrent primary brain tumors: a multicenter real-world Turkish Oncology Group (TOG) study
Zehra Sucuoğlu İşleyen, Şaban Seçmeler, Abdullah Sakin, et al.
Page
of 68
Search research articles
Search
Showing results (661-670 of 676) with videos related to
Sort By:
Page
of 68
Frontiers in Immunology
|
September 12, 2022
Serum cytokine levels are associated with tumor progression during FOLFIRINOX chemotherapy and overall survival in pancreatic cancer patients
Fleur van der Sijde, Willem A Dik, Dana A M Mustafa, et al.
Journal for Immunotherapy of Cancer
|
July 22, 2020
Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model
Sai Ping Lau, Nadine van Montfoort, Priscilla Kinderman, et al.
Scientific Reports
|
November 29, 2025
Treatment outcomes of sunitinib and/or pazopanib in advanced alveolar soft part sarcoma: A Turkish Oncology Group (TOG) study
Zehra Sucuoğlu İşleyen, Seval Ay, Ertuğrul Bayram, et al.
Kidney International
|
December 21, 2023
Multiomic profiling of transplant glomerulopathy reveals a novel T-cell dominant subclass
Iacopo Cristoferi, Hilal Varol, Myrthe van Baardwijk, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 1, 2022
Autologous dendritic cells pulsed with allogeneic tumour cell lysate induce tumour-reactive T-cell responses in patients with pancreatic cancer: A phase I study
S P Lau, L Klaase, M Vink, et al.
Therapeutic Advances in Medical Oncology
|
August 23, 2021
Circulating <i>TP53</i> mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX
Fleur van der Sijde, Zakia Azmani, Marc G Besselink, et al.
Techniques in Coloproctology
|
April 15, 2024
Comparative study of laparoscopic ventral mesh rectopexy versus perineal stapler resection for external full-thickness rectal prolapse in elderly patients: enhanced outcomes and reduced recurrence rates-a retrospective cohort study
T A A M Habeeb, M Podda, M Chiaretti, et al.
International Journal of Molecular Sciences
|
October 23, 2021
Serum miR-373-3p and miR-194-5p Are Associated with Early Tumor Progression during FOLFIRINOX Treatment in Pancreatic Cancer Patients: A Prospective Multicenter Study
Fleur van der Sijde, Marjolein Y V Homs, Marlies L van Bekkum, et al.
World Journal of Gastrointestinal Surgery
|
March 10, 2023
Hepatobiliary manifestations following two-stages elective laparoscopic restorative proctocolectomy for patients with ulcerative colitis: A prospective observational study
Tamer A A M Habeeb, Abdulzahra Hussain, Mauro Podda, et al.
BMC Cancer
|
February 14, 2026
Evaluation of the efficacy and tolerability of bevacizumab-based treatments in recurrent primary brain tumors: a multicenter real-world Turkish Oncology Group (TOG) study
Zehra Sucuoğlu İşleyen, Şaban Seçmeler, Abdullah Sakin, et al.
Page
of 68